Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2012-06-20

Clinical Trial Update: Citriodiol® and Impetigo [Phase 2, Phase 3]

View source ↗

Summary

This document reports an ongoing Phase 2/Phase 3 trial of Citriodiol® for impetigo, with the trial status not disclosed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Citriodiol®

Snippet

Sponsor: Royal North Shore Hospital | Conditions: Impetigo | Phase 2, Phase 3 | Status: UNKNOWN